Logo image of SCAN.CA

LIBERTY DEFENSE HOLDINGS LTD (SCAN.CA) Stock Fundamental Analysis

TSX-V:SCAN - CA53044R8839 - Common Stock

0.26 CAD
+0.02 (+6.12%)
Last: 9/4/2025, 7:00:00 PM
Fundamental Rating

1

Taking everything into account, SCAN scores 1 out of 10 in our fundamental rating. SCAN was compared to 24 industry peers in the Commercial Services & Supplies industry. SCAN has a bad profitability rating. Also its financial health evaluation is rather negative. SCAN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SCAN has reported negative net income.
In the past year SCAN has reported a negative cash flow from operations.
In the past 5 years SCAN always reported negative net income.
In the past 5 years SCAN always reported negative operating cash flow.
SCAN.CA Yearly Net Income VS EBIT VS OCF VS FCFSCAN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

The Return On Assets of SCAN (-103.79%) is worse than 91.67% of its industry peers.
The Return On Equity of SCAN (-616.65%) is worse than 70.83% of its industry peers.
Industry RankSector Rank
ROA -103.79%
ROE -616.65%
ROIC N/A
ROA(3y)-159.03%
ROA(5y)-143.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SCAN.CA Yearly ROA, ROE, ROICSCAN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

SCAN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SCAN.CA Yearly Profit, Operating, Gross MarginsSCAN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600

More info and screens

1

2. Health

2.1 Basic Checks

SCAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SCAN has been increased compared to 1 year ago.
Compared to 5 years ago, SCAN has more shares outstanding
SCAN has a worse debt/assets ratio than last year.
SCAN.CA Yearly Shares OutstandingSCAN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SCAN.CA Yearly Total Debt VS Total AssetsSCAN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

SCAN has an Altman-Z score of -8.87. This is a bad value and indicates that SCAN is not financially healthy and even has some risk of bankruptcy.
SCAN has a worse Altman-Z score (-8.87) than 87.50% of its industry peers.
A Debt/Equity ratio of 0.81 indicates that SCAN is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.81, SCAN is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Altman-Z -8.87
ROIC/WACCN/A
WACC10.79%
SCAN.CA Yearly LT Debt VS Equity VS FCFSCAN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M

2.3 Liquidity

A Current Ratio of 0.89 indicates that SCAN may have some problems paying its short term obligations.
SCAN has a Current ratio of 0.89. This is in the lower half of the industry: SCAN underperforms 62.50% of its industry peers.
SCAN has a Quick Ratio of 0.89. This is a bad value and indicates that SCAN is not financially healthy enough and could expect problems in meeting its short term obligations.
SCAN has a Quick ratio (0.83) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.89
Quick Ratio 0.83
SCAN.CA Yearly Current Assets VS Current LiabilitesSCAN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 29.49% over the past year.
The Revenue has grown by 63.38% in the past year. This is a very strong growth!
EPS 1Y (TTM)29.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.01%
Revenue 1Y (TTM)63.38%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%66.97%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SCAN.CA Yearly Revenue VS EstimatesSCAN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 500K 1M 1.5M 2M
SCAN.CA Yearly EPS VS EstimatesSCAN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 -2 -4 -6 -8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SCAN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SCAN.CA Price Earnings VS Forward Price EarningsSCAN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SCAN.CA Per share dataSCAN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SCAN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIBERTY DEFENSE HOLDINGS LTD

TSX-V:SCAN (9/4/2025, 7:00:00 PM)

0.26

+0.02 (+6.12%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)08-11 2025-08-11
Earnings (Next)11-26 2025-11-26
Inst Owners8.13%
Inst Owner ChangeN/A
Ins Owners0.99%
Ins Owner ChangeN/A
Market Cap18.71M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.55
P/FCF N/A
P/OCF N/A
P/B 9.44
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.71
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0.05
BVpS0.03
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -103.79%
ROE -616.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-159.03%
ROA(5y)-143.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 22.19%
Cap/Sales 11.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.89
Quick Ratio 0.83
Altman-Z -8.87
F-Score4
WACC10.79%
ROIC/WACCN/A
Cap/Depr(3y)44.5%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.01%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)63.38%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%66.97%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-18.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.05%
OCF growth 3YN/A
OCF growth 5YN/A